EverHint — Insider Trading Radar - November 17, 2025

November 17, 2025

Scope: Today’s Form 4 highlights with emphasis on open-market buys/sells and material 10%-owner moves. Each item includes fresh, primary-source context.

10%-Owner & Control-Level Activity

CELH — Celsius Holdings
Who: Dean & Deborah DeSantis; William H. Milmoe (10% owners)
What: Tranche settlements tied to a prepaid variable forward/GRAT structure; reference cap $37.0234; multiple 11/12–11/17 settlements. → SEC Form 4s (details in “Remarks”). (SEC)

NQP — Nuveen PA Quality Muni Income Fund
Who: Saba Capital (10% owner)
What: Sale 174,255 @ $12.19 (≈**$2.12M**), 11/14 → Form 4.
Context: Part of ongoing CEF rotations (see also ECAT, MEGI below). (SEC)

ECAT — BlackRock ESG Capital Allocation Term Trust
Who: Saba Capital (10% owner)
What: Sales 90,456 @ $16.30 and 62,082 @ $16.45, 11/13–11/14 → Form 4. (SEC)

MMTX — MilunaC Technology
Who: MilunaC Technology Ltd (10% owner)
What: Buys incl. 194,100 @ $11.54 (and smaller adds), 11/14–11/15 → Form 4. (Issuer-specific context limited today.)

Notable Insider Buys (Open-Market / Offering Participation)

BHVN — Biohaven

• John W. Childs Revocable Trust (Director): Buy 3,333,333 @ $7.50 (≈**$25.0M**), 11/13 → Form 4
• Gregory Bailey (Director): Buy 400,000 @ $7.50 (≈**$3.0M**), 11/13 → [Form 4]
  Context: Insider participation in the company’s upsized equity offering; Biohaven disclosed ~$200M gross proceeds. (SEC)

PGNY — Progyny

• Peter Anevski (CEO/Director): Buy 79,500 @ $24.288 (≈**$1.93M**), 11/13 → Form 4.
  Context: Fresh open-market purchase; company IR shows filings cadence around Nov. (SEC)

TREX — Trex Company

• Prithvi Gandhi (CFO): Buy 15,000 @ $31.9227 (≈**$478,841**), 11/14 → Form 4.
  Context: Additional coverage flagged today’s purchase. (SEC)

MSM — MSC Industrial

• Philip Peller (Director): Buy 6,666 @ $90.14 (≈**$600,873**), 11/13 → Form 4.
  Context: Multiple outlets noted the director add. (Investing.com)

CRVO — CervoMed

• John J. Alam (CEO/Director, 10% owner) and Matthew Winton (Chief Commercial & Business Officer): Buys on 11/12–11/15 → Form 4s.
  Context: Follows Nov 4 update on FDA alignment for neflamapimod in DLB and the company’s Q3 release last week. (ir.cervomed.com)

VANI — Vivani Medical

• Gregg Williams (Director, 10% owner): Buy 264,550 @ $1.26 (≈**$333,333**), 11/15 → Form 4. (No new IR release today.)

Notable Insider Sells (Open-Market / CEF Rotations)

NQP — Nuveen PA Quality Muni Income Fund — Saba Capital (10% owner) sold 174,255 shares (see above). (SEC)
ECAT — BlackRock ESG Capital Allocation Term Trust — Saba Capital (10% owner) sold 90,456 and 62,082 shares. (SEC)
MEGI — CBRE Global Infrastructure Megatrends Term Fund — Saba Capital (10% owner) sold 31,509 shares, 11/14 → Form 4. (Yahoo Finance)
KLTR — Kaltura — Eyal Manor (Director) sold 27,956 @ $1.82 (≈**$50.9K**), 11/14 → Form 4. (One-off size.)

Quick Take

• Largest ticket: BHVN insider participation (~$28M across two directors) tied to an upsized equity raise—constructive signal. (SEC)
• CEO/CFO conviction: PGNY CEO and TREX CFO made notable open-market buys—positive insider read-throughs. (SEC)
• CEF flows: Saba remains active (trim NQP/ECAT/MEGI). Treat as structural positioning vs. issuer fundamentals. (SEC)
• Biotech follow-up: CRVO insider adds shortly after FDA pathway alignment update—supportive for near-term sentiment. (ir.cervomed.com)

Independent research. No hype, no pumps, no paid promotions — just clean, data-driven signals and concise context.